|

|

File No. PSUR-13011(14)/3/2025-eoffice Government of India Directorate General of Health Services Central Drugs Standard Control Organization Office of Drugs Controller General (India) (Post Marketing Drugs Safety Monitoring Division) senescent eens

Circular

FDA Bhawan, New Delhi Dated: 20 NOV 2025

To,

All State/UT Licensing Authorities

Subject: Display of PvPI QR Code and Toll-Free Number at Retail and Wholesale Pharmacy Stores for Adverse Drug Reaction (ADR) Reporting—regarding

As part of the ongoing commitment to strengthening patient safety and pharmacovigilance in the country, it has been decided during the 16" Working Group Meeting of the Pharmacovigilance Programme of India (PvPI) held on 18.06.2025, that all State Licensing Authorities and Union Territory Drug Licensing Authorities shall ensure the display of the designated QR Code (attached herewith) at a prominent location within every retail and wholesale pharmacy premises across the country.

|

Additionally, the toll-free number of PvPI—1800-180-3024—shall also be clearly displayed with the QR Code at each pharmacy outlet. This measure will facilitate seamless reporting of Adverse Events/Adverse Drug Reactions (AE/ADRs) by the public and healthcare professionals through the indigenous PvP! Adverse Drug Reaction Monitoring System (ADRMS).

It is therefore requested to initiate immediate action for implementation of the above instructions within your jurisdiction. Kindly ensure wide dissemination among all the license holders and monitor strict compliance with these directives to promote drug safety and protect public health.

|

Your continual support and cooperation towards strengthening pharmacovigilance practices in India are highly appreciated.

==> picture [164 x 31] intentionally omitted <==

----- Start of picture text -----<br> (Dr. ngh Raghuvanshi)<br>Drugs Controller General (India)<br>----- End of picture text -----<br>

Copy to: -

1. All Stakeholders through the website of CDSCO

2. All Zonal, Sub-zonal Offices of CDSCO

3. Secretary cum Scientific Director, PvP], IPC, Ghaziabad

if you experience/suspect any adverse event after taking medicine, kindly report through the following modes:

==> picture [310 x 78] intentionally omitted <==

----- Start of picture text -----<br> /4<br>CB PvPl Toll Free Number<br>----- End of picture text -----<br>

==> picture [222 x 218] intentionally omitted <==

----- Start of picture text -----<br> Lz<br>a i | _ = —_<br>oie =f = <<<br>et ao-<br>Ac =", a” alls<br>Sea ote<br>. , A .. al as<br>a eS ae<br>a<br>7<br>Oo Sten ee<br>----- End of picture text -----<br>

Scan this QR code to report suspected ADR

=i sm Issued in Public Interest by yg National Coordination Centre-Pharmacovigilance Programme of India A WHO Collaborating Centre for Pharmacovigilance in Public Health Programmes and Regulatory Services Ee) Indian Pharmacopoeia Commission —— Ministry otHealtinas an / ‘ govt. ofpila ire Tel.: 0120-2783400, ore3s01 ores? email oval : te: www.ipc.gov.in